A study has shown that tanshinone IIA can reduce the expression of FOXM1 in gastric tumors, resulting in a rise in p21 and a decrease in PCNA and Ki-67 proteins, ultimately inhibiting the proliferation of SGC-7901 cells (Yu et al., 2017). The gene discussed is FOXM1; the disease is gastric neoplasm.